Surmodics | SRDX - Interest Expense On Debt


Surmodics reported $884K in Interest Expense on Debt for its fiscal quarter ending in September of 2024.





Interest Expense On Debt Change Date
Abbott USD 68M 26M Mar/2026
Align Technology USD 16.04M 14.04M Dec/2025
Anika Therapeutics 179.39M 556.84M Mar/2026
Arrowhead Research USD 22.5M 811K Dec/2025
Artivion USD 5.53M 589K Dec/2025
Baxter International USD 58M 14M Sep/2025
Boston Scientific USD 90M 0 Mar/2026
EDAP TMS EUR 49K 8K Sep/2025
Edwards Lifesciences USD 35.9M 2.7M Dec/2025
Haemonetics USD 7.4M 190K Dec/2025
Heron Therapeutics USD 600K 100K Dec/2024
J&J USD 43M 25M Mar/2026
Merit Medical Systems USD 6.53M 162K Mar/2026
Mesa Laboratories USD 3.02M 180K Sep/2024
Nektar Therapeutics USD 9.77M 3.75M Dec/2025
Option Care Health USD 13.3M 570K Mar/2026
Stryker USD 46.29B 45.68B Mar/2026
Surmodics USD 884K 5K Sep/2024
Trinity Biotech USD 3.33M 50K Sep/2025